Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.

Publication ,  Journal Article
Mascarenhas, J; Kosiorek, H; Prchal, J; Yacoub, A; Berenzon, D; Baer, MR; Ritchie, E; Silver, RT; Kessler, C; Winton, E; Finazzi, MC; Rosti, V ...
Published in: Leukemia
December 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Leukemia

DOI

EISSN

1476-5551

Publication Date

December 2019

Volume

33

Issue

12

Start / End Page

2974 / 2978

Location

England

Related Subject Headings

  • Venous Thrombosis
  • Thrombocythemia, Essential
  • Recombinant Proteins
  • Prospective Studies
  • Polyethylene Glycols
  • Polycythemia Vera
  • Mesenteric Veins
  • Interferon-alpha
  • Immunology
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mascarenhas, J., Kosiorek, H., Prchal, J., Yacoub, A., Berenzon, D., Baer, M. R., … Hoffman, R. (2019). A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. Leukemia, 33(12), 2974–2978. https://doi.org/10.1038/s41375-019-0524-7
Mascarenhas, J., H. Kosiorek, J. Prchal, A. Yacoub, D. Berenzon, M. R. Baer, E. Ritchie, et al. “A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.Leukemia 33, no. 12 (December 2019): 2974–78. https://doi.org/10.1038/s41375-019-0524-7.
Mascarenhas, J., et al. “A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.Leukemia, vol. 33, no. 12, Dec. 2019, pp. 2974–78. Pubmed, doi:10.1038/s41375-019-0524-7.
Mascarenhas J, Kosiorek H, Prchal J, Yacoub A, Berenzon D, Baer MR, Ritchie E, Silver RT, Kessler C, Winton E, Finazzi MC, Rambaldi A, Vannucchi AM, Leibowitz D, Rondelli D, Arcasoy MO, Catchatourian R, Vadakara J, Rosti V, Hexner E, Kremyanskaya M, Sandy L, Tripodi J, Najfeld V, Farnoud N, Salama ME, Weinberg RS, Rampal R, Goldberg JD, Mesa R, Dueck AC, Hoffman R. A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. Leukemia. 2019 Dec;33(12):2974–2978.

Published In

Leukemia

DOI

EISSN

1476-5551

Publication Date

December 2019

Volume

33

Issue

12

Start / End Page

2974 / 2978

Location

England

Related Subject Headings

  • Venous Thrombosis
  • Thrombocythemia, Essential
  • Recombinant Proteins
  • Prospective Studies
  • Polyethylene Glycols
  • Polycythemia Vera
  • Mesenteric Veins
  • Interferon-alpha
  • Immunology
  • Humans